GEN Exclusives

More »

Apr. 15, Vol. 25, No. 8

    • Point of View

      • Some Activist Groups Exibit a
      • Chemistry Nobel Laureate Irving Langmuir related in a landmark 1953 speech his visit to the laboratory of J.B. Rhine at Duke University where Rhine was claiming results of ESP experiments that could not be predicted by chance, and which he ascribed ... more »
    • FDA News and Analysis

      • Submitting Pharmacogenomic Data to the FDA
      • The FDA announced the availability of its long-awaited pharmacogenomic data guidance on March 23 (70 FR 14698). The document, entitled Guidance for Industry: Pharmacogenomic Data Submissions (and referred to in this article as the Final Guidance), r ... more »
    • Feature Articles

      • Biotechnology in Vancouver
      • The "3rd Annual BioPartnering North America" conference, held February 68 in Vancouver, British Columbia, brought together 900 representatives of 450 companies worldwide to promote new collaborations and alliances. Sponsored by the Techno ... more »
      • California Stem Cell Institute Starts Slowly
      • With the passage of Proposition 71 (the California Stem Cell Research and Cures Initiative) last November, California voters gave their approval for the state to spend $3 billion on stem cell research to find treatments for Parkinson's disease, ... more »
      • Interfering with RNA
      • Post-transcriptional control though RNA interference (RNAi) is a remarkably well conserved mechanism found throughout eukaryotic organisms from plants through fungi, nematodes, and people. RNAi, while it most likely evolved as one defense mechanism ... more »
      • Microarray Technologies Advancing Medicine
      • Microarrays allow researchers to better understand the relationship between gene expression and physiological function. Thanks to many recent technology and bioinformatics advances, clinicians are starting to apply this information. Experts in this ... more »
      • NIH Ethics Regulations
      • Gail Dutton
      • The NIH Assembly of Scientists, an organization formed in response to February's NIH ethics regulations, presented a counter proposal that addresses issues raised in the original NIH document while still safeguarding the agency's integrity. ... more »
      • Putting the Squeeze on Manufacturing
      • To continue to be profitable in the future, biomanufacturers should take some tips from the food business. That was one of the take home messages at the recent "Biologicals Manufacturing Summit," which was held in London and organized by V ... more »
      • Sample Management and Storage Systems
      • Many pharmaceutical companies and research institutions are looking for more efficient ways of managing their high throughput drug discovery processes. HTS typically requires the assembly of focused sublibraries for primary HTS screens, cherry picki ... more »
      • Turbocharging Expression Microarrays
      • In this post-genomic era, drug discovery and other basic life science research sectors are increasingly utilizing nucleic acid microarrays for comprehensive gene expression studies. Drug discovery labs depend on microarrays to help elucidate disease ... more »

Jobs

GEN Jobs powered by HireLifeScience.com connects you directly to employers in pharma, biotech, and the life sciences. View 40 to 50 fresh job postings daily or search for employment opportunities including those in R&D, clinical research, QA/QC, biomanufacturing, and regulatory affairs.
 Searching...
More »

GEN Poll

More » Poll Results »

Stopping Research Fraud

What is the best approach to curbing scientific misconduct and outright fraud?